Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience.

Rihawi K, Giannarelli D, Galetta D, Delmonte A, Giavarra M, Turci D, Garassino M, Tiseo M, Barbieri F, Panni S, Ardizzoni A. BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience. J Thorac Oncol. 2019 03; 14(3):e57-e59.

View in: PubMed

collapse authors with profiles